Experimental vaccine for deadly tickborne virus effective in cynomolgus macaques

An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study. The study comes about three years after the same research group developed the macaque model for CCHFV. No specific treatments or vaccines for CCHFV exist.